New HIV prevention program lets young kenyan women choose their protection
NCT ID NCT06566430
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called PrEP My Way that helps young women aged 16-24 in Kisumu, Kenya stay on HIV prevention medication. Participants can choose between a daily pill, a long-acting shot, or a vaginal ring, plus get support from peers. The goal is to see if offering choices and home delivery of supplies helps women use PrEP consistently.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kenya Medical Research Institute
RECRUITINGKisumu, Kenya
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a robot help stroke survivors with HIV walk again?
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Can a Father-Focused program curb HIV, substance abuse, and violence?
- Smart pill bottles and health coaches team up to tackle HIV in the deep south
- Could routine STI screening during pregnancy prevent preterm births?
- Could HIV and age weaken vaccine protection? study investigates